Measurement of anti-D intrinsic affinity with unlabeled antibodies

Transfusion

Volumn 44, Issue 3, 2004, Pages 399-406

  Debbia, Martine ^a   Lambin, Patrick ^a,b  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BENZYLSULFONYL FLUORIDE; D ANTIBODY; D ANTIGEN; IODINE 125; MONOCLONAL ANTIBODY; OCTOXINOL; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ANTIBODY LABELING; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BINDING ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; PHENOTYPE; SCATCHARD PLOT;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IODINE RADIOISOTOPES; PHENOTYPE; RH-HR BLOOD-GROUP SYSTEM;

EID: 1642331486     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.00651.x     Document Type: Article

References (28)

1. Mollison PL, Engelfriet CP, Contreras M. The Rh blood group system. In: Mollisson PL, Englefriet CP, Contreras M, eds. Blood transfusion in clinical medicine. Oxford: Blackwell, 1997;10:151-85.
2. Scott M. Section 1A: Rh serology. Coordinator's report. Transfus Clin Biol 2002;9:23-9.
3. Bloy C, Blanchard D, Lambin P, et al. Human monoclonal antibody against Rh(D) antigen: partial characterization of the Rh(D) polypeptide from human erythrocytes. Blood 1987;69:1491-7.
4. Kumpel BM. Monoclonal anti-D development programme. Transpl Immunol 2002;10:199-204.
5. Urbaniak SJ. Consensus conference on anti-D prophylaxis, April 7 & 8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/ Royal College of Obstetrician and Gynaecologists. Transfusion 1998;38:97-9.
6. Cooper N, Woloski BM, Fodero EM, et al. Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy? 2002;99:1922-7.
7. Kumpel BM. On the mechanism of tolerance to the Rh D antigen mediated by passive anti-D (Rh D prophylaxis). Immunol Lett 2002;82:67-73.
8. Huang CH, Liu PZ, Cheng JG. Molecular biology and genetics of the Rh blood group system. Semin Hematol 2000;37:150-65.
9. Chang TY, Siegel DL. Genetic and immunological properties of phage-displayed human anti-Rh(D) antibodies: implications for Rh(D) epitope topology. Blood 1998;91: 3066-78.
10. Liu W, Avent ND, Jones JW, et al. Molecular configuration of Rh D epitopes as defined by site-directed mutagenesis and expression of mutant Rh constructs in K562 erythroleukemia cells. Blood 1999;94:3986-96.
11. Larsson A. Regression analysis of simulated radio-ligand equilibrium experiments using seven different mathematical models. J Immunol Methods 1997;206:135-42.
12. 125I-labelled human monoclonal IgG antibodies. Vox Sang 1988;55:165-70.
13. 125I-labelled anti-D. Vox Sang 1987;53:175-80.
14. Hughes-Jones NC, Gorick BD, Beale D. Multiple epitopes recognised by human monoclonal IgM anti-D antibodies. Vox Sang 1990;59:112-5.
15. Fjeld JG, Skretting A. Evaluation of labelled monoclonal antibodies by simultaneous estimation of the association constant, the immunoreactive fraction, and the number of effective binding sites on the specific target. J Immunol Methods 1992;151:97-106.
16. Matzku S, Kirchgessner H, Dippold WG, et al. Immuno-reactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule. Eur J Nucl Med 1985;11: 260-4.
17. Nikula TK, Bocchia M, Curcio MJ, et al. Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity. Mol Immunol 1995;32:865-72.
18. Fuchs H, Gessner R. Iodination significantly influences the binding of human transferrin to the transferrin receptor. Biochim Biophys Acta 2002;1570:19-26.
19. Ahaded A, Debbia M, Beolet M, et al. Evaluation by enzyme-linked immunosorbent assay of IgG anti-D and IgG subclass concentrations in immunoglobulin preparations. Transfusion 1999;39:515-21.
20. Lambin P, Ahaded A, Debbia M, et al. An enzyme-linked immunosorbent assay for the quantitation of IgG anti-D and IgG subclasses in the sera of alloimmunized patients. Transfusion 1998;38:252-61.
21. Lambin P, Debbia M, Puillandre P, et al. IgG1 and IgG3 anti-D in maternal serum and on the RBCs of infants suffering from HDN: relationship with the severity of the disease. Transfusion 2002;42:1537-46.
22. Goossens D, Champomier F, Rouger P, et al. Human monoclonal antibodies against blood group antigens. Preparation of a series of stable EBV immortalized B clones producing high levels of antibody of different isotypes and specificities. J Immunol Methods 1987;101:193-200.
23. Jefferis R, Reimer CB, Skvaril F, et al. Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol Lett 1985;10:223-52.
24. Bye JM, Carter C, Cui Y, et al. Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift. J Clin Invest 1992;90:2481-90.
25. Braden BC, Goldman ER, Mariuzza RA, et al. Anatomy of an antibody molecule: structure, kinetics, thermodynamics and mutational studies of the antilysozyme antibody D1.3. Immunol Rev 1998;163:45-57.
26. Jones JW, Lloyd-Evans P, Kumpel BM. Quantitation of Rh D antigen sites on weak D and D variant red cells by flow cytometry. Vox Sang 1996;71:176-83.
27. Ong GL, Mattes MJ. Re-evaluation of the concept of functional affinity as applied to bivalent antibody binding to cell surface antigens. Mol Immunol 1993;30:1455-62.
28. Friguet B, Chaffotte AF, Djavadi-Ohaniance L, et al. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods 1985;77:305-19.